Annual Report

 It has been a very busy and productive year for the UKMS Guidelines group. There have been three important guidelines published in the British Journal of Haematology. These include the good practice papers on imaging and high-risk myeloma and the guideline on the diagnosis and management of monoclonal gammopathy of renal significance. 

The guidelines on relapsed/refractory myeloma have been submitted for publication and the guideline on amyloidosis screening is in the final stages prior to submission. We also have writing groups working on a guideline for the management of myeloma bone disease which will be hugely informative, and a guideline on the use of bispecific antibodies in relapsed/refractory myeloma also planned.

The BSH Scientific Conference has asked us to chair a session dedicated to myeloma guidelines, in recognition of their significance. 

I would like to offer a sincere thank you and good bye to Dr Simon Stern who has stepped down as the Chair of the UKMS Guidelines Group after many years.  We welcome three new colleagues to the BSH Guidelines Taskforce who are supporting the development of guidelines for myeloma: Dr Kevin Boyd, Dr Chris Parrish and Dr Faisal Basheer.

Thank to you all Executive members and colleagues who have supported the production of these guidelines.

Dr Tracey Chan
Guidelines Chair
March 2025